Renaissance Technologies - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 117 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.25 and the average weighting 0.5%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$1,690,000
-84.6%
101,500
-86.6%
0.00%
-66.7%
Q2 2018$10,963,000
+167.8%
757,100
+134.9%
0.01%
+50.0%
Q1 2018$4,093,000
+528.7%
322,300
+1111.7%
0.00%
+300.0%
Q1 2016$651,000
-89.6%
26,600
-77.5%
0.00%
-92.9%
Q2 2015$6,266,000118,3000.01%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,628,328$33,869,00014.72%
Foresite Capital Management II, LLC 995,396$20,704,00010.39%
Cormorant Asset Management, LP 1,581,604$32,897,0004.43%
DAFNA Capital Management LLC 221,013$4,597,0004.04%
New Leaf Venture Partners, L.L.C. 228,428$4,751,0003.40%
Partner Investment Management, L.P. 63,571$1,322,0001.75%
Iguana Healthcare Management, LLC 140,000$2,912,0001.74%
PFM Health Sciences, LP 2,913,951$60,610,0001.71%
Redmile Group, LLC 920,550$19,147,0001.65%
SECTORAL ASSET MANAGEMENT INC 669,351$13,923,0001.54%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders